Showing results (271-280 of 393) with videos related to
Sort By:
Pageof 40
Bioconjugate Chemistry|July 1, 1990
Antibody-directed fibrinolysis: a bispecific (Fab')2 that binds to fibrin and tissue plasminogen activatorM S Runge, C Bode, C E Savard, et al.The American Journal of Cardiology|June 15, 1991
Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarctionE von Hodenberg, J Kreuzer, M Hautmann, et al.Journal of Molecular and Cellular Cardiology|April 1, 1987
Thrombolysis by a fibrin-specific antibody Fab'-urokinase conjugateC Bode, M S Runge, J B Newell, et al.The Journal of Biological Chemistry|August 5, 1987
Characterization of an antibody-urokinase conjugate. A plasminogen activator targeted to fibrinC Bode, M S Runge, J B Newell, et al.Journal of Thrombosis and Haemostasis : JTH|May 9, 2009
Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779J L Diener, H A Daniel Lagassé, D Duerschmied, et al.Thrombosis and Haemostasis|August 24, 1999
A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregationJ Ruef, T K Nordt, K Peter, et al.Histochemistry and Cell Biology|January 1, 1997
Histones: genetic diversity and tissue-specific gene expressionD Doenecke, W Albig, C Bode, et al.Der Nervenarzt|November 8, 2005
[Therapeutically induced arteriogenesis in the brain. A new approach for the prevention of cerebral ischemia with vascular stenosis]H-J Busch, I Buschmann, E Schneeloch, et al.Clinical Cardiology|April 17, 2001
Clusters of life-threatening ventricular arrhythmias in patients with implanted cardioverter-defibrillators: prevalence, characteristics, and risk stratificationA Grom, T W Baron, T S Faber, et al.Thrombosis and Haemostasis|March 1, 2000
Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approachesJ Ruef, K Peter, T K Nordt, et al.Pageof 40